Create account

Coverage dated September 10, 2026 to September 11, 2026

Trump surgeon general nominee discloses tobacco, pharma investments

Headline from News Nation Now

President Donald Trump’s surgeon general nominee reported investments in the tobacco company Philip Morris International as well as beverage companies Monster Beverage Corp, Coca-Cola Co. and Pepsi Co., according to financial disclosures released Thursday.

News Nation Now's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

14 articles, oldest first.

  1. Bloomberg

    Trump’s Surgeon General Pick Invested in Tobacco, McDonald’s (opens Bloomberg)

    Published

    Bloomberg's feed description

    President Donald Trump’s nominee for surgeon general reported investments in companies including McDonald’s Corp., Monster Beverage Corp., Coca-Cola Co. and the tobacco company Philip Morris International Inc., according to her financial disclosures made public Thursday.

  2. News Nation Now

    Trump surgeon general nominee discloses tobacco, pharma investments (opens News Nation Now)

    Published

    News Nation Now's feed description

    President Donald Trump’s surgeon general nominee reported investments in the tobacco company Philip Morris International as well as beverage companies Monster Beverage Corp, Coca-Cola Co. and Pepsi Co., according to financial disclosures released Thursday.

  3. Gizmodo

    Trump’s Pick for Surgeon General Holds Investments in Tech, Tobacco, Fast Food, and Big Pharma (opens Gizmodo)

    Published

    Gizmodo's feed description

    Former Fox News contributor Nicole Saphier is Trump's third nominee for Surgeon General in his second term.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Related updates

Separate coverage close to this update in time and subject.

Trump surgeon general nominee discloses tobacco, pharma investments | Since Then